- Exchange: Stockholm
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Medivir AB+ Add to Watchlist
MVIRB:SS124.7500 SEK 4.5000 3.48%
As of 12:02:13 ET on 10/31/2014.
Company Profile for Medivir AB (MVIRB)
Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.
Key Executives for Medivir AB (MVIRB)
|Niklas PragerPresident/CEO||Christina KassbergExec VP:Finance & Administration|
|Paul WallaceExec VP:Business Development||Rein PiirExec VP:Corporate Affairs|
|Hakan WallinExec VP:Corporate Dev||Richard BethellExec VP:Discovery Research|
|Henrik KrookExec VP:Commercial||Charlotte EdeniusExec VP:Development|